How A Pharma Giant Used The ‘Fiscal Cliff’ Deal To Profit At The Expense Of Elderly Americans

How A Pharma Giant Used The ‘Fiscal Cliff’ Deal To Profit At The Expense Of Elderly Americans: Amgen Inc. — one of America’s largest biotech and pharmaceutical companies — has had a rough couple of months. In December, the firm was fined $762 million for illegally promoting drugs and defrauding Medicare. And now lawmakers from both sides of the aisle are looking to undo a little-noticed provision that Amgen successfully lobbied for [...]/p